Average Co-Inventor Count = 2.79
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Reveragen Biopharma, Inc. (12 from 15 patents)
2. Children's Research Institute (2 from 10 patents)
3. Children's National Medical Center (1 from 73 patents)
4. Validus Genetics (1 from 1 patent)
5. Validus Biopharma Inc. (1 from 1 patent)
17 patents:
1. 11833159 - Non-hormonal steroid modulators of NF-kB for treatment of disease
2. 11690853 - Non-hormonal steroid modulators of NF-κβ for treatment of disease
3. 10857161 - Non-hormonal steroid modulators of NF-kB for treatment of disease
4. 10799514 - Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
5. 10464967 - Non-hormonal steroid modulators of NF-κβ for treatment of disease
6. 10266824 - Methods and agents to increase therapeutic dystrophin expression in muscle
7. 10206933 - Non-hormonal steroid modulators of NF-kB for treatment of disease
8. 10000525 - Non-hormonal steroid modulators of NF-κB for treatment of disease
9. 9861642 - Methods for diagnosing and treating asthma
10. 9649320 - Non-hormonal steroid modulators of NF-κB for treatment of disease
11. 9637738 - Methods and agents to increase therapeutic dystrophin expression in muscle
12. 9434758 - Non-hormonal steroid modulators of NF-κB for treatment of disease
13. 9198921 - Non-hormonal steroid modulators of NF-κB for treatment of disease
14. 9188581 - Methods for diagnosing and treating asthma
15. 8673887 - Non-hormonal steroid modulators of NF-kB for treatment of disease